E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 8/3/2005 in the Prospect News Biotech Daily.

Parexel price target upped by Jefferies

Parexel Corp. was maintained by Jefferies & Co. analyst Adam Walsh at an underperform rating but the price target was raised to $17.25 per share from $16.00 following second-quarter results. Parexel shares Wednesday were up $0.32, or 1.60%, at $20.37 on volume of 99,587 shares versus the three-month running average of 173,603 shares.


© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.